Mari Uehara

No ORCID on file · 7 papers in corpus
lab-animal 2024
Ulipristal (UPA) effects on rat ovaries: Unraveling follicle dynamics, ovulation inhibition, and safety implications for prolonged use
Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/j.reprotox.2024.108571

Ulipristal (UPA), a selective progesterone receptor modulator, has both agonistic and antagonistic effects on progesterone receptors. UPA suppresses ovulation by inhibiting the luteinizing hormone (LH) surge from the pituitary gland; howeve…

lab-animal 2023
Effect of long-term treatment of ulipristal acetate on rat ovarian tissue
·doi:10.21203/rs.3.rs-2847062/v1

Abstract Ulipristal (UPA), a selective progesterone receptor modulator, has both agonistic and antagonistic effects on progesterone receptors. UPA suppresses ovulation by inhibiting the luteinizing hormone (LH) surge from the pituitary glan…

observational 2022
Evaluation of atherosclerosis-related biomarkers during perimenopause: A prospective cohort study in women with endometriosis

Aim: Endometriosis is linked to asymptomatic atherosclerosis and increases the risk of cardiovascular disease (CVD). Vascular function tests are used to assess atherosclerosis, an important indicator of CVD development. In this study, we ai…

observational 2022
Evaluation of atherosclerosis-related biomarkers during perimenopause: A prospective cohort study in women with endometriosis
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15447

AIM: Endometriosis is linked to asymptomatic atherosclerosis and increases the risk of cardiovascular disease (CVD). Vascular function tests are used to assess atherosclerosis, an important indicator of CVD development. In this study, we ai…

observational 2022
Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study
Endocrine journal ·doi:10.1507/endocrj.ej22-0158

Dienogest (DNG) is widely used to treat dysmenorrhea associated with estrogen-dependent diseases such as endometriosis and adenomyosis. DNG becomes unnecessary after menopause when estrogen secretion declines drastically. However, there are…

observational 2022
Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study
BMC women's health ·doi:10.1186/s12905-022-01711-3

BACKGROUND: In women with endometriosis, the association between ovarian function, hormones, and bone mineral density (BMD) is unclear. Therefore, this study aimed to elucidate the association between changes in bone mineral density (BMD) a…

observational 2021
Relationship Between Bone Mineral Density and Ovarian Function in Perimenopausal Women With Endometriosis: A Prospective Study
·doi:10.21203/rs.3.rs-778798/v1

Abstract Background In women with endometriosis, the association between ovarian function, hormones, and bone mineral density (BMD) is unclear. Therefore, this study aimed to elucidate the correlation between changes in bone mineral density…